Residual disease after neoadjvant chemotherapy and debulking surgery in patients with advanced ovarian cancer (prospective, randomized phase II clinical trial to select primary chemotherapy with carboplatin and docetaxel in patients with advanced ovarian cancer stage FIGO IIIC and IV Primovar)

Poelcher, M. and Mahner, S. and Ortmann, O. and Hilfrich, J. and Diedrich, K. and Breitbach, P. and Hoess, C. and Moebus, V. and Thomssen, C. and Kuhn, W. (2008) Residual disease after neoadjvant chemotherapy and debulking surgery in patients with advanced ovarian cancer (prospective, randomized phase II clinical trial to select primary chemotherapy with carboplatin and docetaxel in patients with advanced ovarian cancer stage FIGO IIIC and IV Primovar). ONKOLOGIE, 31 (Suppl1). pp. 108-109. ISSN 0378-584X

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Frauenheilkunde und Geburtshilfe (Schwerpunkt Frauenheilkunde)
Depositing User: Petra Gürster
Date Deposited: 12 Jan 2021 16:12
Last Modified: 12 Jan 2021 16:12
URI: https://pred.uni-regensburg.de/id/eprint/31461

Actions (login required)

View Item View Item
pred is powered by EPrints 3.4 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.